Posts
February 21 2014
IZEA, Inc. announced the closing of their PIPE offering in the amount of $12,000,000. EG&S acted as counsel to the Investor.
February 18 2014
Oxigene Inc. announced the closing of their Registered Direct offering in the amount of $11,999,996. EG&S acted as counsel to the Placement Agent.
February 18 2014
DARA BioSciences, Inc. announced the closing of their Registered Direct offering in the amount of $5,990,375. EG&S acted as counsel to the Placement Agent.
February 13 2014
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) announced the closing of a $60 million registered direct financing with institutional investors. EG&S acted as counsel to BDSI.
February 13 2014
LabStyle Innovations Corp. (OTCQB:DRIO) announced the pricing of a $4.1 million private investment in public equity (PIPE) offering to institutional and accredited investors. EG&S acted as counsel to LabStyle.
February 12 2014
Uranium Resources, Inc. announced the closing of their Registered Direct offering in the amount of $10,296,000. EG&S acted as counsel to the Investor.
February 07 2014
ARCA Biopharma, Inc. announced the closing of their Registered Direct offering in the amount of $8,697,587. EG&S acted as counsel to the Placement Agent.
February 05 2014
MELA Sciences Inc. announced the closing of their PIPE offering in the amount of $12,300,000. EG&S acted as counsel to the Placement Agent.